XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Statement of Cash Flows [Abstract]    
Net income $ 23,121 $ 16,343
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of assets (51) (26)
Depreciation and amortization 8,363 7,437
Write-off of software development project 0 153
Loss in equity method investment, before tax 28 0
Gain on bargain purchase of a business (8,388) 0
Deferred income taxes 1,163 2,499
Noncash compensation related to stock plans 7,976 2,750
Excess tax benefit of options exercised and restricted stock units vested 0 (28)
Provision (recovery) for doubtful accounts 13 (266)
Changes in operating assets and liabilities, net of acquisitions:    
Trade accounts receivable (30,254) (28,228)
Inventories (9,796) (13,912)
Trade accounts payable 3,209 7,273
Income taxes payable 3,681 6,289
Accrued profit sharing trust contributions (4,036) (3,552)
Accrued cash profit sharing and commissions (1,287) 2,605
Other current assets (695) (3,230)
Accrued liabilities (845) (6,192)
Long-term liabilities 87 (1,853)
Accrued workers’ compensation 9 (121)
Other noncurrent assets 210 2,162
Net cash used in operating activities (7,492) (9,897)
Cash flows from investing activities    
Capital expenditures (15,760) (6,972)
Asset acquisitions, net of cash acquired (26,289) 0
Proceeds from sale of property and equipment 53 40
Net cash used in investing activities (41,996) (6,932)
Cash flows from financing activities    
Deferred and contingent consideration paid for asset acquisition (65) (27)
Repurchase of common stock 0 (3,502)
Capital lease borrowings 2,131 0
Issuance of common stock 314 1,012
Excess tax benefit of options exercised and restricted stock units vested 0 28
Dividends paid (8,538) (7,709)
Cash paid on behalf of employees for shares withheld (5,124) (3,871)
Net cash used in financing activities (11,282) (14,069)
Effect of exchange rate changes on cash and cash equivalents 1,292 4,101
Net decrease in cash and cash equivalents (59,478) (26,797)
Cash and cash equivalents at beginning of period 226,537 258,825
Cash and cash equivalents at end of period 167,059 232,028
Noncash activity during the period    
Noncash capital expenditures 4,817 266
Dividends declared but not paid 8,578 7,729
Contingent consideration for acquisition 1,139 0
Issuance of Company’s common stock for compensation $ 412 $ 315